about
Pharmacotherapy of methamphetamine addiction: an updateGlutamatergic substrates of drug addiction and alcoholismmGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in ratsModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionMethamphetamine-induced behavioral sensitization in a rodent model of posttraumatic stress disorder.Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine.NrCAM-regulating neural systems and addiction-related behaviors.Glutamate receptors in the dorsal hippocampus mediate the acquisition, but not the expression, of conditioned place aversion induced by acute morphine withdrawal in rats.mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapseTargeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives.A non-parametric approach for detecting gene-gene interactions associated with age-at-onset outcomesCognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulantsElectrophysiological and structural alterations in striatum associated with behavioral sensitization to (±)3,4-methylenedioxymethamphetamine (Ecstasy) in rats: role of drug context.Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans.Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders.The importance of the excitatory amino acid transporter 3 (EAAT3)Blockade of mGluR5 in the nucleus accumbens shell but not core attenuates heroin seeking behavior in rats.Post-translational modification biology of glutamate receptors and drug addictionSix-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study.Small conductance calcium-activated potassium type 2 channels regulate alcohol-associated plasticity of glutamatergic synapses.Enhanced sensitivity to attenuation of conditioned reinstatement by the mGluR 2/3 agonist LY379268 and increased functional activity of mGluR 2/3 in rats with a history of ethanol dependenceFos and glutamate AMPA receptor subunit coexpression associated with cue-elicited cocaine-seeking behavior in abstinent rats.C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response.Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration.S-(N, N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study.Antagonism of metabotropic glutamate 1 receptors attenuates behavioral effects of cocaine and methamphetamine in squirrel monkeys.TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity?Riluzole and D-amphetamine interactions in humans.Neurobiological processes in adolescent addictive disorders.Corticostriatal Afferents Modulate Responsiveness to Psychostimulant Drugs and Drug-Associated Stimuli.Region-specific involvement of AMPA/Kainate receptors in Fos protein expression induced by cocaine-conditioned cuesAdaptive plasticity of NMDA receptors and dendritic spines: implications for enhanced vulnerability of the adolescent brain to alcohol addiction.Dephosphorylation of GluN2B C-terminal tyrosine residues does not contribute to acute ethanol inhibition of recombinant NMDA receptorsCeftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats.Metabotropic glutamate 7 (mGlu7) receptor: a target for medication development for the treatment of cocaine dependence.The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.Genome-wide association study of smoking initiation and current smoking.Sensitizing regimens of (+/-)3, 4-methylenedioxymethamphetamine (ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat.Positive or negative allosteric modulation of metabotropic glutamate receptor 5 (mGluR5) does not alter expression of behavioral sensitization to methamphetamine.
P2860
Q24648913-9922A7D0-AD5F-401A-885D-52C029AE4F3AQ24648924-785DAD51-0464-4734-839C-BBEF66DC02DFQ24658267-427BFB6C-A908-471F-A2FF-7969803EDA3BQ27014154-333BCD92-99A9-4EEF-9B15-698385D5CEE2Q30435613-48079665-78D6-4E6F-86F9-E99E0F65D7A7Q30490470-7EBB9132-A36A-41D5-914B-73C633BAE362Q30525650-E548C2B1-FD62-43B0-894F-A40EFCB585E6Q33555649-B2BD0250-00CB-4F23-A201-67F5D4E2FF8AQ33819245-D4AC8C4D-B3AF-4CA5-AD6B-08B6DD5D9D97Q33821312-BFF5808D-FE84-44F1-936C-856AF6C9A2F3Q33864940-14FC8964-EAD5-4DCF-83DD-BF59E166B4EAQ33936309-9CC773EA-FA59-41E0-9532-6BD3CC878CEEQ34086410-C157B3C2-B546-457D-B49F-C2A000D93D64Q34329874-F971BD04-D830-4E98-857A-0E3C53997494Q34459309-5ACB3C90-73A3-42E4-B578-41C3941DEE21Q34472695-816E92E9-5F27-4B62-889B-5672BBAB8BD6Q34528594-055E764E-1EBA-4A02-8220-E68238C0B0E0Q34664568-F34E5DA2-54AA-48D5-BFE7-249761BAD538Q34706306-98E7DB34-98F5-4520-86E0-FAB1978B7144Q34773574-3E2D6B8B-ECCF-4DBA-96A6-AE0A0AEEA586Q35012634-BAEF3E80-43B1-4802-B702-B1A90879F99AQ35592069-69C872CB-1533-4B35-8E7B-734A864FD7EEQ35809536-76EA2AA4-0B38-412C-9087-4A761154F227Q35845409-6A6DCA79-6DD2-4213-8E64-FC501AECA32DQ36233639-F759AEB2-2AB3-4E9D-AD97-3BC739F68025Q36243255-9DC83EA6-A036-4613-BC9A-061D9D0F7610Q36296859-BC95F7C2-225A-43C5-9379-7AE4773E5FC4Q36415334-5120C330-94DC-44D7-BAAC-62DBD6318565Q36484852-9640C5D3-7B62-43A5-B42A-821B2CD4BE1BQ36508688-083D284A-475C-4EB6-BC51-8ACE93DBAFF9Q36565674-358927FF-D1F2-4249-B62C-7D9933EE1AA7Q36703310-4DD16FAC-07F6-4301-9992-74BBF667CD36Q36732795-98BADB79-D767-43E2-928B-4395C06A957EQ36741688-E0CA11BB-483C-4E30-A029-6F90A67BC356Q36853227-B784574D-40E8-46C4-9968-C3F5954C5FB2Q37103693-A8DB64BF-399C-4EC0-99D0-3178DA9DE714Q37142233-C80F626F-5A17-4813-AC37-E9288BAF4D3FQ37156043-C5677E1B-F439-4F05-B9CC-69320F174B3AQ37159976-66700800-1CB7-4D62-BAF8-D0D0DA59A370Q37272553-F4FBE5CE-9827-41BD-9357-A7A2A4B24AE8
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Glutamatergic mechanisms in addiction.
@ast
Glutamatergic mechanisms in addiction.
@en
type
label
Glutamatergic mechanisms in addiction.
@ast
Glutamatergic mechanisms in addiction.
@en
prefLabel
Glutamatergic mechanisms in addiction.
@ast
Glutamatergic mechanisms in addiction.
@en
P356
P1433
P1476
Glutamatergic mechanisms in addiction.
@en
P2093
Schmidt WJ
Tzschentke TM
P2888
P304
P356
10.1038/SJ.MP.4001269
P407
P577
2003-04-01T00:00:00Z
P5875
P6179
1015612681